Long-term effects of L-carnitine on hyperammonemia and hepatic encephalopathy in patients with liver cirrhosis: a multicenter retrospective study

Long-term L-carnitine administration effectively reduces BAC and hepatic encephalopathy-related hospitalizations with excellent safety. Higher initial doses (>1500 mg/day) achieve more rapid BAC normalization and should be considered for patients with significant hyperammonemia.